ODIN PHARMACEUTICALS
Live / Registered — Registered (as of 04 Oct 2022)
What this means for you
Registered since 04 Oct 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Oct 2028: the §8 declaration of use).
Record
- Serial number
- 97021902
- Registration number
- 6865437
- Mark type
- Stylized text
- Filed
- 10 Sept 2021
- Published for opposition
- 19 Jul 2022
- Registered
- 04 Oct 2022
- Next maintenance filing
- §8 declaration of use, due by 04 Oct 2028 (grace period to 04 Apr 2029)
- Attorney of record
- Nicole K. McLaughlin
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals for others
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Mendham Holdings LLC, Somerset, NJ, US
- Mendham Holdings LLC, Somerset, NJ, US
- Mendham Holdings LLC, Somerset, NJ, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 04 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 19 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Jul 2022 — PUBLISHED FOR OPPOSITION
- 29 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Jun 2022 — EXAMINER'S AMENDMENT ENTERED
- 15 Jun 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 Jun 2022 — EXAMINERS AMENDMENT E-MAILED
- 15 Jun 2022 — EXAMINERS AMENDMENT -WRITTEN
- 03 Feb 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Feb 2022 — NON-FINAL ACTION E-MAILED
- 03 Feb 2022 — NON-FINAL ACTION WRITTEN
- 01 Feb 2022 — ASSIGNED TO EXAMINER
- 19 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED